Expertise in
19
conditions

Dr. Ricardo Mccall

Gastroenterology
Gastroenterology Associates Of Swla LLC
555 Doctor Michael Debakey Dr Ste 101, 
Lake Charles, LA 
Expertise in
19
conditions
Gastroenterology Associates Of Swla LLC
555 Doctor Michael Debakey Dr Ste 101, 
Lake Charles, LA 

Overview

Ricardo Mccall is a Gastroenterologist in Lake Charles, Louisiana. Dr. Mccall is highly rated in 19 conditions, according to our data. His top areas of expertise are Angiodysplasia of the Colon, Diarrhea, Trichohepatoenteric Syndrome, Endoscopy, and Colonoscopy.

His clinical research consists of participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Gastroenterology

Licenses

Internal Medicine in LA

Hospital Affiliations

Methodist Hospitals Of Memphis
Parkview Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Gastroenterology Associates of Swla LLC
555 Doctor Michael Debakey Dr Ste 101, Lake Charles, LA 70601
Other Locations
Parkview Health System Inc.
11104 Parkview Circle Dr Ste 310, Fort Wayne, IN 46845

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Completed
Publish Date: August 11, 2025
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Enrollment Status: Terminated
Publish Date: April 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
View 9 Less Clinical Trials
Similar Doctors
Expertise in
61
conditions
Dr. Sarpreet Basra
Gastroenterology
Expertise in
61
conditions
Dr. Sarpreet Basra
Gastroenterology

Lake Charles Memorial Hospital

1701 Oak Park Blvd, 
Lake Charles, LA 
 (883.4 miles away)
337-494-4785
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sarpreet Basra is a Gastroenterologist in Lake Charles, Louisiana. Dr. Basra is highly rated in 61 conditions, according to our data. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Chronic Erosive Gastritis, Painful Swallowing, Gastrectomy, and Endoscopy.

Expertise in
66
conditions
Dr. Frank Marrero
Gastroenterology
Expertise in
66
conditions
Dr. Frank Marrero
Gastroenterology

Memorial Digestive Health Center

2770 3rd Ave, 
Lake Charles, LA 
 (883.3 miles away)
337-494-4785
Languages Spoken:
English
See accepted insurances

Frank Marrero is a Gastroenterologist in Lake Charles, Louisiana. Dr. Marrero is highly rated in 66 conditions, according to our data. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Painful Swallowing, Swallowing Difficulty, Endoscopy, and Gastrostomy.

Expertise in
52
conditions
Dr. Khaled Nour
Gastroenterology
Expertise in
52
conditions
Dr. Khaled Nour
Gastroenterology

Office

2770 3rd Ave, 
Lake Charles, LA 
 (883.3 miles away)
337-494-4785
Languages Spoken:
English
See accepted insurances

Khaled Nour is a Gastroenterologist in Lake Charles, Louisiana. Dr. Nour is highly rated in 52 conditions, according to our data. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Barrett Esophagus, Chronic Erosive Gastritis, Gastrectomy, and Endoscopy.

Frequently Asked Questions about Dr. Ricardo Mccall

How do I make an appointment with Dr. Ricardo Mccall?

You can book an appointment with Dr. Ricardo Mccall by calling their office at 337-439-0762. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ricardo Mccall a top-rated expert for Angiodysplasia of the Colon?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ricardo Mccall is classified as an Advanced expert for Angiodysplasia of the Colon, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ricardo Mccall specialize in?

While Dr. Ricardo Mccall is a Gastroenterology, they have specific expertise in Angiodysplasia of the Colon, Diarrhea, and Trichohepatoenteric Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Ricardo Mccall accept my insurance?

Dr. Ricardo Mccall accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 337-439-0762 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccall's expertise for a condition
ConditionClose
      View All 19 Advanced Conditions
      View All 58 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile